Using ‘omics to unravel the pathophysiology and repurpose drugs to treat ME/CFS [ 11/1/2020 - 10/31/2025 ]

Research Grant

Brief description The cause(s) of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not well known, but may involve altered function by the component of the cell that produces energy (mitochondria). We will use cutting edge stem cell technology to investigate this in detail and generate vital new knowledge that could identify new targets for the treatment of ME/CFS. We will also use a complex technology to screen a library of drugs to identify those that may be useful in the treatment of ME/CFS.

Funding Amount $1,083,010

Funding Scheme Targeted Calls for Research

Chief Investigator Prof Ken Walder

Notes Myalgic Encephalomyelitis and Chronic Fatigue Syndrome